CONSOLIDATED BALANCE SHEETS - USD ($)	Jul. 31, 2015	Jul. 31, 2014
Current Assets:
Cash and cash equivalents	$ 749,965	$ 3,269,489
Other current assets	51,240	201,314
Total Current Assets	801,205	3,470,803
Property and Equipment (Note 3)	2,869	5,293
Patents (Note 4)	1,430,016	2,046,361
TOTAL ASSETS	2,234,090	5,522,457
Current Liabilities:
Accounts payable and accrued expenses (Note 6)	$ 8,018,833	8,034,122
Deferred revenue (Note 6)		223,662
Total Current Liabilities	$ 8,018,833	8,257,784
Derivative Warrant Liability (Note 8 and 9)	2,363,415	2,635,643
Derivative Additional Investment Rights Liability (Note 8 and 9)	142,662	719,088
Total Liabilities	$ 10,524,410	$ 11,612,515
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 1,500,000,000 shares at July 31. 2015 and July 31, 2014, respectively; 825,496,238 and 778,512,092 issued and outstanding at July 31, 2015 and July 31, 2014, respectively	$ 825,496	$ 778,512
Additional paid-in capital	362,556,710	362,307,678
Accumulated deficit	(372,481,263)	(369,948,322)
Accumulated other comprehensive income	808,737	772,074
Total Stockholders' Deficiency	8,290,320	6,090,058
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$ 2,234,090	$ 5,522,457
Series A Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Series B Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Series C Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Series D Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Series E Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Series F Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock
Series G Convertible Preferred Stock
Stockholders' Deficiency (Notes 9 and 11):
9% Convertible Preferred Stock